Ftse Mib
34.276,59
-0,06%
DAX
18.067,36
-0,36%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
63.165,18
-1,05%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ DermTech Inc (DMTK) DermTech Inc (DMTK) Notizie

DermTech Inc

DMTK
0,595
0,00 (0,00%)
30 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202422:15BWDermTech to Explore Strategic Alternatives and Implement..
01/4/202422:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
08/3/202414:05BWDermTech Presents Research Abstracts at the 2024 American..
08/3/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:17EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:05EDGAR2Form 8-K - Current report
29/2/202422:01BWDermTech Reports Fourth-Quarter 2023 Financial Results
13/2/202414:05BWDermTech Announces Release Date for Fourth-quarter 2023..
31/1/202422:32EDGAR2Form 8-K - Current report
31/1/202422:30BWDermTech Announces Additional Restructuring Actions to Focus..
18/1/202414:05BWDermTech Announces Positive Topline Results From a Study..
16/1/202414:05BWDermTech Simplifies the DermTech Melanoma Test (DMT) by..
10/1/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:00BWDermTech Announces Positive Topline Results From Trust 2..
14/12/202322:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12/12/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
21/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07/11/202319:57PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02/11/202321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:09EDGAR2Form 8-K - Current report
02/11/202321:01BWDermTech Reports Third-Quarter 2023 Financial Results
31/10/202310:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
24/10/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/10/202314:05BWDermTech Announces Release Date for Third-Quarter 2023..
23/9/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202302:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/9/202322:05BWDermTech Grants New CCO Mark Aguillard Inducement Award..
19/9/202314:05BWDermTech Announces Contracts With Highmark for the..
13/9/202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202302:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202314:10EDGAR2Form 8-K - Current report
11/9/202314:05BWDermTech Appoints Mark Aguillard as Chief Commercial Officer
25/8/202314:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12/8/202300:44EDGAR2Form 144 - Report of proposed sale of securities
07/8/202322:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/8/202322:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:07EDGAR2Form 8-K - Current report
03/8/202322:01BWDermTech Reports Second-Quarter 2023 Financial Results
19/7/202314:00BWDermTech Announces Favorable Coverage Policy With Blues Plan..
17/7/202314:00BWDermTech Announces Release Date for Second-Quarter 2023..
14/7/202302:17EDGAR2Form 144 - Report of proposed sale of securities
13/7/202322:09EDGAR2Form 8-K/A - Current report: [Amend]
Apertura: Min: Max:
Chiusura: 0,595

La tua Cronologia

NASDAQ
DMTK
DermTech
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network